In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer
Author:
Affiliation:
1. Exelixis, Inc., South San Francisco, California.
Publisher
Mary Ann Liebert Inc
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.liebertpub.com/doi/pdf/10.1089/thy.2013.0137
Reference54 articles.
1. Cancer Statistics, 2009
2. A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis
3. Medullary thyroid cancer: early detection and novel treatments
4. Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas
5. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A simple and sensitive liquid chromatography triple quadrupole mass spectrometry method for the determination of XL092 in monkey plasma and its application to pharmacokinetic study;Biomedical Chromatography;2024-01-30
2. Major adverse cardiovascular events of vascular endothelial growth factor tyrosine kinase inhibitors among patients with different malignancy: A systemic review and network meta-analysis;Journal of the Chinese Medical Association;2023-11-22
3. Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer;New England Journal of Medicine;2023-11-16
4. Cabozantinib for different endocrine tumours: killing two birds with one stone. A systematic review of the literature;Endocrine;2023-10-18
5. Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET;Cancers;2023-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3